Obermatt
See Similar Stocks →

Artivion

NYQ:AORT · US2289031005
Health Care Equipment & SuppliesMedium

360

49
EV / EBIT15
Price / Owner Earnings97
Owner Earnings Yield1
Dividend Yield1
Price/Sales65
EV / Gross Profit47
Price/Book64
Return on Capital59
Cash Return on Capital49
Return on Equity59
EBIT Margin65
Gross Profitability50
Cash Conversion88
Accruals36
Owner Earnings Margin49
Sales growth48
Profit Growth52
Long-Term EPS Growth49
Reinvestment17
Price momentum32
Debt load53
Refinancing88
Debt Payback1
Liquidity56
Analyst ratings84
Opinion Changes13
Price Target Upside96
Market mood36
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Artivion clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeNYSE
Founded1984
Employees648
Websiteartivion.com
ISINUS2289031005
Last UpdateApr 2, 2026
Indices
D.J. US Medical Equipment
Themes
CardiovascularSurgeryManufacturing

Description

Artivion, Inc. (Artivion) engages in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major produ…

Analysis

Middle-of-the-road

Artivion, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 10/20 on our value-creation score: creating some value. Analysts lean positive.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
42
2026

All-time high

42

Jun 2026

All-time low

40

Mar 2026

Average rank

41

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
65
—
—
—
Price/Earnings
14
—
—
—
Price/Book
64
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
42
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Artivion with its peers
LeMaitre Vascular
NMQ:LMAT
78
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Edwards Lifesciences
NYQ:EW
55
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
TELA Bio
NMQ:TELA
19
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
AtriCure
NMQ:ATRC
75
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
CONMED
NYQ:CNMD
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Sight Sciences
NSQ:SGHT
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →